Potential lung cancer vaccine shows renewed promise
Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of tumors in mice with lung cancer. ...
Mar 20, 2014
0
0